Research programme - cell therapies - Outpace Bio
Alternative Names: Cell therapies - OutpaceLatest Information Update: 29 Apr 2021
At a glance
- Originator Outpace Bio
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 08 Apr 2021 Preclinical trials in Unspecified in USA, prior to April 2021 (Outpace Bio pipeline, April 2021)